First patients receive experimental Cancer-Fighting duo

NCT ID NCT05471856

Summary

This is the first study in people to test a new drug called BI 1703880 when given with an existing immunotherapy drug, ezabenlimab. The main goal is to find the safest and most effective dose of the new combination for adults with advanced solid tumors that have not responded to standard treatments. Participants receive both drugs through an IV and are closely monitored for side effects and how their cancer responds.

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for SOLID TUMORS are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • CIO Clara Campal

    RECRUITING

    Madrid, 28050, Spain

    Contact Phone: •••-•••-•••• Email: •••••@•••••

  • Churchill Hospital

    RECRUITING

    Oxford, OX3 7LE, United Kingdom

    Contact Phone: •••-•••-•••• Email: •••••@•••••

  • Hospital Clinico Universitario De Valencia

    RECRUITING

    Valencia, 46010, Spain

    Contact Phone: •••-•••-•••• Email: •••••@•••••

  • Hospital Universitari Vall D Hebron

    RECRUITING

    Barcelona, 08035, Spain

    Contact Phone: •••-•••-•••• Email: •••••@•••••

  • Instituto Valenciano de Oncología

    RECRUITING

    Valencia, 46009, Spain

    Contact Phone: •••-•••-•••• Email: •••••@•••••

  • Japanese Foundation for Cancer Research

    RECRUITING

    Tokyo, Koto-ku, 135-8550, Japan

    Contact Phone: •••-•••-•••• Email: •••••@•••••

  • John Theurer Cancer Center

    RECRUITING

    Hackensack, New Jersey, 07601, United States

    Contact Phone: •••-•••-•••• Email: •••••@•••••

  • National Cancer Center Hospital East

    RECRUITING

    Chiba, Kashiwa, 277-8577, Japan

    Contact Phone: •••-•••-•••• Email: •••••@•••••

  • Saitama Medical University International Medical Center

    NOT_YET_RECRUITING

    Saitama, Hidaka, 350-1298, Japan

    Contact Phone: •••-•••-•••• Email: •••••@•••••

  • The Royal Marsden Hospital, Chelsea

    RECRUITING

    London, SW3 6JJ, United Kingdom

    Contact Phone: •••-•••-•••• Email: •••••@•••••

  • The Royal Marsden Hospital, Sutton

    RECRUITING

    Sutton, SM2 5PT, United Kingdom

    Contact Phone: •••-•••-•••• Email: •••••@•••••

  • Valkyrie Clinical Trials

    RECRUITING

    Los Angeles, California, 90067, United States

    Contact Phone: •••-•••-•••• Email: •••••@•••••

  • Yale University School of Medicine

    RECRUITING

    New Haven, Connecticut, 06511, United States

    Contact Phone: •••-•••-•••• Email: •••••@•••••

Conditions

Explore the condition pages connected to this study.